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Abstract
Cerebral edema, a complication that can occur in acute ischemic or hemorrhagic strokes,
can lead to detrimental effects. Hypertonic saline therapy is use to obtain therapeutic
hypernatremia to prevent further cerebral edema. In a neuroscience intensive care unit (ICU)
setting, patients admitted with acute stroke and at risk for cerebral edema, are treated with
hypertonic saline solution and the rate adjustment according to plasma serum sodium results
every 4-6 hours. After a 10-day Reflective Practice Log, I gained insight of this issue. After a
literature review, approval The University of Texas at El Paso Institutional Review Board (IRB),
I started my Doctor of Nursing Practice (DNP) Project, “Implementation of Hypertonic Saline
Scale Protocol in a Neuroscience ICU”. Evidence based guidelines founded hypertonic saline
sliding scale protocol, allowed less time for undershooting or overshooting infusion rates.
Permitted for serum plasma draw every 6 hours and included use of salt tablets with the
hypertonic saline solution. Patients enrolled during this project, achieved serum sodium goal of
145mEq/L within a 24-hour period compared to previous, 36-52 hours range. In addition, the
length of stay (LOS) decreased by 8 days, eliminated the complications from prolonged
hypertonic saline infusion, lowered costs, and provided faster disposition.
Keywords: Hypertonic, sliding scale, acute stroke, cerebral edema
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Implementation of Hypertonic Saline Sliding Scale Protocol in a Neuroscience ICU
Introduction
According to the National Institute of Health (NIH), evidence-based practice is defined
as, the conscientious and judicious use of current best evidence in making decisions of the care
of an individual patient. In the current neuroscience ICU a 10-day reflective practice log was
done, which consisted of documenting all patients seen over a 3 week period. The documentation
of each patient included demographics such as sex, age, their history, diagnosis, assessment,
assessment tools and plan of care. After completion of reflective practice log, all patients seen
were then analyzed, which resulted in new insight gained and questioned if I was using current
best evidence in making decisions about care for each patient.
The NIH formatted an approach to help summarize the findings in reflective log to
question the effects and outcomes found in my reflective practice log. This approach is known as
the PICOT question format, which signifies population, intervention, comparison, outcome and
time. Three PICOT questions were formatted after the completion of 10-day reflective practice
log. The first was the use of hypertonic saline solution to prevent cerebral edema in acute stroke
patients. The hypertonic saline solution used was either 1.8% or 3%, and prescribed at various
rates of infusion. When providers were questioned why a certain rate was prescribed along with
certain hypertonic saline solution, there was no concrete answer or rationalization provided. The
second PICOT question, dealt with those patients admitted for subarachnoid hemorrhage (SAH)
that resulted from an aneurysm rupture. The goal of magnesium level for a SAH patient was to
have a level greater than 2mg/dL, however it was found that magnesium replacement was not
part of the SAH protocol for those patients admitted with SAH. The last PICOT, dealt with
mechanical ventilation management for acute stroke patients. Those stroke patients who were
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intubated for over 10 days and difficult to wean off mechanical ventilator were started on
positive end expiratory pressure (PEEP) maneuvers, for alveoli recruitment, to assess with
extubating. PEEP maneuvers were started at day 10 versus day 7 of intubation, if PEEP
maneuvers were started sooner length of mechanical ventilation for those patients can be
shortened.
After analyzing each PICOT question, I concluded to conduct a literature review
pertaining to hypertonic saline in a neuroscience intensive care unit (ICU) in order to find the
best current practice. A literature review was done specific to the use of hypertonic saline to
prevent cerebral edema in a neuroscience ICU setting. The literature review determined that best
practice guidelines were not used appropriately pertaining to the use of hypertonic saline to
prevent cerebral edema in the acute stroke patients. Therefore, hospitalized patients ages 18-99
who suffer acute stroke within the first 24-48 hours who are at risk for cerebral edema, will
obtain serum sodium goal greater than 145mEq/L within a 24-hour period with the use of a
hypertonic saline sliding scale. With this information I was able to propose my doctorate of
nursing practice (DNP) quality improvement (QI) project proposal, “Implementation of
Hypertonic Saline Sliding Scale Protocol in a Neuroscience ICU”. This QI project was approved
by the Institutional Review Board (IRB) at The University of Texas at El Paso, and at my work
site, Texas Tech University Health Sciences Center Department of Neurology.
Literature Review
In a neuroscience intensive care unit (ICU), cerebral edema is a major complication
second to ischemic or hemorrhagic stroke. Patients who suffer acute stroke often experience
neuronal damage from cerebral edema which will cause an increase in intracranial pressure (ICP)
(Wright, 2012). The avoidance of hyponatremia is crucial to prevent herniation that can happen
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if the brain is allowed to swell due to hyponatremia (Sterns, Hix and Silver, 2013). Therapeutic
hypernatremia is desired for stroke patients at risk for cerebral edema and herniation. After a tenday reflective practice, patients were consistently found to be at risk for cerebral edema. The
goal of using hypertonic saline solution is to obtain a serum sodium goal of 145-150mEq/L, to
prevent cerebral edema in those acute stroke patients who are at risk. However, to achieve this,
there is no standard protocol or algorithm. Every provider is left to their own discretion to order
either 1.8 % or 3% hypertonic saline solution at various rates for intravenous infusion. There is
no concrete rationalization for ordering a particular rate, which leads one to believe that the
infusion rate order is simply a “guesstimate” or an estimate based on a mixture of guesswork and
calculation.
Woo, Rao, Sheridan and Flint (2009) instituted a hypertonic saline sliding scale that is
standardized to minimize variability administration and to calculate safe rates of hypertonic
saline for treating acute neurologic hyponatremia (ANH). ANH is a common phenomenon in
neurocritical care patients who suffer an acute stroke, which can lead to cerebral edema (Woo et
al., 2009). The retrospective review of 49 patients found the sliding scale to be reliable to
achieve sodium concentrations in a safe manner. Use of this protocol was found to greatly
simplify the treatment of ANH. The standardization sliding scale also minimized variability and
allowed for safer rates of sodium correction with minimal time adjusting infusion rates. The use
of a standardized hypertonic saline sliding scale protocol would greatly improve clinical
outcomes in a neuroscience ICU for patients who suffer an acute stroke. Each stroke patient
would be prescribed the same standardized protocol, which would remove the necessity for
guesstimating.
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When it comes to sodium and fluid management, sodium is a major determinant of
neuronal size and therefore hyponatremia is aggressively avoided, hyperosmolarity states result
in cerebral edema (Wright, 2012). Acute stroke patients are quickly placed on hypertonic saline
in a neuroscience ICU setting to prevent cerebral edema. Increasing sodium can also be achieved
with salt tablets; however hypertonic saline is a favorable option because it expands intravascular
volume (Wright, 2012). Protocols for hypertonic saline infusions may vary and adjust the dose
based on the patient’s weight. However, saline infusions should be standardized according to
multiple variables and adjusted according to the patient’s serum sodium level (Wright, 2012).
Another added value of the use of a hypertonic saline sliding scale protocol, was the use of salt
tablets in correlation with hypertonic saline (Wright, 2012). Although this is not a new concept,
it is not currently being practiced within the current neuroscience ICU setting. Woo et al. (2009)
use of salt tablets could be given orally or by nasogastric tube to at allow less time for titration
and minimize overshooting serum sodium. Salt tablets are often prescribed after the target
sodium level is achieved in order to discontinue hypertonic saline without immediately lowering
serum sodium levels in the current neuroscience ICU setting.
In the current neuroscience ICU setting, serum sodium goal of 145-150mEq/L is the
target to prevent cerebral edema. After that goal is established, it is important that serum sodium
concentrations be increased enough to prevent complications and avoid overcorrection rates that
increase the risk iatrogenic brain injury (Sterns et al., 2013). Serum sodium will rise and fall
according to how the brain responds to a changing serum sodium concentration. Therefore,
defining the serum sodium goal is crucial to avoid overcorrection (Sterns et al., 2013). Sterns et.
al. (2013) also found the hypertonic saline sliding scale beneficial when establishing serum
sodium goal and avoiding hyponatremia (Woo et al., 2009).
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The sliding scale included the administration of 3-gram (GM) salt tablets orally or by
gastric tubes, hypertonic saline solution rate started at 20ml/hour and rate adjusted according to
plasma serum sodium levels, and maximum infusion rate of 80ml/hour, revealed an initial rate of
sodium correction of 0.44 +/-0.36 mEq/L per hour. A total of 84.3% of the infusion time was
spent within target sodium range 136-145 mEq/L per hour, 14.9% +/- 18.1% of the time was
spent in mild undershoot (130-135mEq/L), and 0.7% +/- 3.1% was spent overshoot (>145
mEq/L). With the use of a hypertonic saline sliding scale in the current neuroscience ICU
setting, it will prevent overcorrection of serum sodium and limit the complications which could
further lengthen hospital stays.
The registered Nurses’ Association of Ontario (2012) Implementation of Best Practice
Guidelines (BPG) knowledge to practice process was used to transition the knowledge acquired
and place it into action in the current neuroscience ICU setting. This translational framework was
ideal for implementing the project due to suiting transition on a larger scale facility. After the
identification of the problem, the stakeholders were defined, to include myself as part of the
neuroscience ICU provider team, bedside nurse, pharmacy, laboratory, neuroscience ICU
department, emergency department (ED) and patient. Facilitators and barriers were identified,
which will later be discussed. Strategies on how to implement the project were utilized after
facilitators and barriers were identified. Following this step was distinguishing which
implementation strategies would work best with implanting hypertonic saline sliding scale
protocol. The knowledge consumed would help key indicators of the project and evaluate the
outcomes from the implementation of quality improvement based on best practice guidelines.
Once these steps were completed, the process started again and were continued as new
knowledge was gained.
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The proposal of a hypertonic saline sliding scale protocol was brought to the current
neuroscience ICU setting, to safely manage the titration of hypertonic saline solution and utilize
the use of salt tablets to obtain serum sodium goal above 145mEq/L within a 24-hour period.
The use of hypertonic saline sliding scale, standardized infusion rate according to serum sodium
levels and allowed the same dose of salt tablets across the board, which helped evade the
guesstimate factor which was used previously.
Methods
The project which examined the efficacy of the hypertonic saline sliding protocol took
place January 25 to February 26, 2021. Patients 18 years of age and older who suffered an acute
ischemic or hemorrhagic stroke within 24 to 48 hours of admission, at risk for cerebral edema,
and had a measured serum sodium less than 140mEq/L, met the criteria for inclusion in the
hypertonic saline sliding scale protocol. The rationale to start the protocol was to gain a
proactive approach to prevent any complication secondary to cerebral edema. Participants were
started on hypertonic saline sliding scale protocol (Table 1), which was standardized and
included patients who that met criteria. The protocol was based on the work of Woo et al. (2009)
which standardized hypertonic protocol, with the use of 3% and 3 GM salt tabs, with the target
serum sodium of 145mEq/L.
Members of neurocritical care team along with bedside nursing staff were involved to
help with implementation of protocol. Education was provided to prescribers and rationalization
for start of protocol was reviewed. Monitoring of serum sodium levels every 6 hours were the
driving factor with the changing of rate for hypertonic saline infusion. Hypertonic saline solution
that was used was 3% and salt tablets were given to all patient either by mouth or by gastric tube,
every 6 hours regardless of serum sodium level. The implementation of hypertonic saline sliding
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scale relayed information to other members of neurocritical care team in order to maintain
consistency with monitoring serum sodium levels in a 24-hour period.
The quality improvement model chosen to implement the hypertonic saline sliding scale
protocol was the Plan, Do, Study, ACT (PDSA). The PDSA model facilitated the process of
carrying out the plan to implement the protocol and collect data by electronic medical record
(EMR) system. Once the protocol implemented, the serum sodium levels were monitored and
adjusted 3% according to sliding scale. After serum sodium level of 145 achieved, variables that
helped or hindered the achievement of serum sodium goal were studied. The variables as well as
those stakeholders who played a key role in the implementation and success of achieving serum
sodium goal were studied. Changes were made each week and executed until the last week of
implantation of hypertonic saline sliding scale protocol.
During the first week of implanting the hypertonic saline sliding scale in the neuroscience
ICU, education was provided on the sliding scale along with a copy of the standardized
hypertonic sliding scale protocol (Table 1). Emphasis was placed on the importance of
communicating with me when a patient was admitted under the neurocritical care team that met
criteria for the sliding scale. The first patient started on the hypertonic saline sliding scale
protocol, was a 69 year old woman who was admitted on 01/24/202 to neuroscience ICU, found
to have right posterior cerebral artery (PCA) ischemic stroke. Repeat head computerized
tomography (CT) done on 01/25/2021 showed evolving acute right PCA infarct with petechial
hemorrhage, at which time the protocol was started.
The second patient started on protocol, within the first week, was an 84 year old woman
admitted on 01/25/2021 with a left temporal lobe hemorrhage, and was a direct admit from an
outside hospital, deemed to be high risk for developing cerebral edema. Both these patients were
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given salt tablets and started on 3% within a 30-minute window and no delay were found on
implementation of hypertonic saline protocol.
The third patient started on protocol was a 91 year old woman, admitted on 01/26/2021,
found to have a subacute right middle cerebral artery (MCA) ischemic stroke, consider high risk
of developing cerebral edema due to the location of infarct. There was a 2-hour delay with the
start of protocol, due to no neuroscience ICU beds. Patient remained in ED, and insertion of NG
tube was postponed, delaying administration of salt tablets, and bedside ED nurse did not check
orders and inquire to pharmacy about not receiving 3%. At the end of the first week, starting
protocol outside of neuroscience ICU was realized as not ideal, especially since non
neuroscience ICU nurse did not comprehend the crucial importance of starting salt tablets and
3% in order to prevent cerebral edema. It was decided not to start the protocol in the ED, unless
absolutely necessary given high hospital census. To address this issue education and
rationalization on protocol would have to be given to the ED nurse.
The second week of implementing hypertonic saline sliding scale protocol, had an
additional patient who met criteria. The fourth patient started on protocol was a 67 year old man
admitted to neuroscience ICU on 02/02/2021, who had an established right MCA ischemic
stroke, and given location was at high risk for developing cerebral edema. No delay was found
with starting protocol, salt tablets and 3% were started within 30-minute window. However,
there was a delay with serum sodium results and laboratory draw. These delays occurred during
the night shift and were not discovered until the following day. With no updated serum sodium
level, rate infusion adjustment according to sliding scale was not done until the following
morning. It was noted that night coverage provider also did follow up with laboratory
department, laboratory draw was not done on the 6-hour mark. Bedside nurse, who was a
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contract nurse with no neuroscience ICU experience did not realize the importance of monitoring
serum sodium levels while on hypertonic saline. Given these factors, reeducation was given to
bedside nurses on all shifts on protocol and importance of monitoring serum sodium levels.
Follow up was performed with the laboratory department, and an error was found with ordering,
where orders did not cross over to their system and they were unaware of serial laboratory draws.
On third week of implementing protocol, two additional patients were started on hypertonic
saline sliding scale protocol.
The fifth patient was a 63 year old man admitted on 02/11/2021 found to have
acute right MCA ischemic stroke secondary to occlusion and underwent mechanical
thrombectomy. It was determined that the patient would be high risk for developing cerebral
edema and placed immediately on protocol post mechanical thrombectomy. There was no delay
with giving salt tablets and 3%, was taken to neuroscience ICU post procedure.
The sixth and final patient that was started on protocol was a 49 year old man
admitted 02/13/2021 for a subarachnoid hemorrhage (SAH) secondary to aneurysm rupture.
Protocol was started to prevent any complications secondary to SAH especially cerebral edema,
and no delays were found with giving salt tablets or 3%. After the third week, no other patients
were admitted to neuroscience ICU that met criteria for hypertonic saline sliding scale protocol.
Following the four-week period and completion of implementation of protocol, it was
observed that starting the protocol in the neuroscience ICU verses ED made an immense
difference. No postponement of giving salt tablets or 3% was discovered with starting protocol
in the neuroscience ICU. Having a trained neuroscience ICU nurse was a key factor with
implementing protocol and following laboratory draw in order to adjust rate of 3% accordingly.
Members of the Neuroscience ICU staff became more aware and willing to utilize the hypertonic
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sliding scale protocol. The pharmacy increased its’ efficiency in delivering serum sodium and
results to the EMR system for protocols started in the neuroscience ICU. A formal review was
completed prior to starting implementation of hypertonic saline sliding scale protocol in the
current neuroscience ICU setting.
The University of Texas at El Paso IRB determined that this quality improvement
project was not research and therefore exempted it from full review. Code of conduct was held
to highest standard and quality improvement project was done under scope of practice for an
adult gerontology acute care nurse practitioner (AGACNP). Patient privacy was upheld with
password protected access and Health Insurance Portability and Accountability Act (HIPPA)
standards. No conflict of interest was found while completing this quality improvement project.
Results
With looking at previous year during same timeframe, four patients were started on
hypertonic saline wither 1.8% or 3% to prevent cerebral edema, it took anywhere from 36-52
hours achieve serum sodium of 145mEq/L. The implementation of hypertonic saline sliding
scale protocol found that all patients started on the standardized scale achieved the serum sodium
goal of 145mEq/L or higher within a 24-hour period. Table 2 shows modifications made to
timeframe during the quality improvement project, in order to achieve the serum sodium goal for
those patients that met criteria for protocol. Despite the delays that were mention, all 6 patients
who were started on the hypertonic saline sliding scale protocol achieved a serum sodium of
145mEq/L or greater within the 24-hour period. The biggest modification that was done during
the implementation of protocol, was to start protocol in the neuroscience ICU. Also, education
to the neurocritical care team and neuroscience ICU nursing staff, once understood the
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rationalization of protocol was not only to achieve sodium goal but prevent cerebral edema for
occurring or worsening.
The utilization of the standardized protocol effectively required less time to achieve
serum sodium goal. Figure 1 shows that the serum sodium levels rose steadily, with using the
hypertonic saline sliding scale protocol, which allow achievement goal with not over or under
correction. This is beneficial to avoid complications with overuse of hypertonic saline, which
can create more issues and prolong hospitalizations. The average hospital stays for the 6 patients
who were on the hypertonic saline sliding scale protocol was 11 days. This was significantly
lower than the average for the four patients treated last year, at 19 days. Figure 2 shows the
hospital stay length for each patient and their disposition upon discharge from hospital. Among
those six patients, three were able to transfer out of neuroscience ICU to a medical floor and
three patients were discharged from neuroscience ICU to either a skilled nursing facility (SNF),
inpatient rehab facility or home with home health. Figure 3 shows disposition for all six patients
who received the protocol. Half the patient went to an inpatient rehab facility, which after an
acute stroke either hemorrhagic or ischemic is the disposition aim.
It is relative to say that by implanting the hypertonic saline protocol not only achieved a
serum sodium of 145mEq/L or greater within a 24-hour period, but it also prevented cerebral
edema from occurring or worsening for all six patients who were on protocol. No adverse
consequences were found with any of the patients who were started on protocol. An unexpected
benefit found was a dramatic decrease in length of hospital stay compared to the patients treated
last year without being on protocol.
Discussion
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The use of hypertonic saline sliding scale was found useful in obtaining the serum
sodium goal of 145mEq/L or greater within a 24-hour period, which excluded the estimation
factor with an infusion rate of 3 percent. Administering 3 GM of salt tablets every 6 hours
allowed minimal use of hypertonic saline and prevented any adverse effects from under or
overshooting infusion rate. The serum sodium goal was achieved while the sliding scale allowed
a proactive approach with preventing cerebral edema and related complications. Those patients
who initiated this protocol benefited from a shortened average hospital to stay and a faster
disposition.
Similar to Woo et al. (2009) retrospective study the standardized scale, the hypertonic
saline sliding scale protocol was found to simplify the avoidance of cerebral edema for those
acute stroke patients. The hypertonic saline sliding scale showed a steady increase in serum
sodium over a 24-hour period, which limited overcorrecting serum sodium levels that could lead
to further complications. The current cost of a 500-liter bag of 3% is $17 compared to 96 cents
for a 24-hour dose of salt tablets. Utilization of the hypertonic saline sliding scale protocol
therefore results in a considerable cost savings.
This was a quality improvement implementation project. Therefore, it was not restricted
by research limitations. Patients who met the criteria for hypertonic saline sliding scale protocol
during the timeframe were initiated on protocol. The use of hypertonic saline sliding scale
protocol made the estimation factor with rate infusion of hypertonic saline obsolete and allowed
the use of salt tablets. The standardization of the protocol was found to be valuable in achieving
the serum sodium goal of 145mEq/L or greater in a 24-hour period and prevented cerebral
edema. In the future, this protocol will be utilized for those patients who met criteria in the
current neuroscience ICU setting.
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Tables
Table 1 Hypertonic saline sliding scale protocol.
● Patient with diagnosed with acute stroke and at risk for cerebral edema will be admitted
to the neuroscience ICU.
● Baseline plasma serum sodium level will be obtained, if <140mEq/L Hypertonic saline
sliding scale will be initiated.
● Hypertonic saline sliding scale protocol prescribed:

3 grams salt tablets (orally or gastric tube) every 6 hours plus 3% hypertonic saline will
be started 20ml/hour, rate adjusted according to plasma serum sodium results to be obtain
every 6 hours.
Serum Sodium

Change infusion rate

<130mEq/L

Increase by 20ml/hour (maximum 80ml/hour)

130-135mEq/L

Increase by 10ml/hour (maximum 80ml/hour)

136-145mEq/L

No change in infusion rate

>145mEq/L

Hold infusion, check serum sodium follows sliding scale.

● Documentation on all patients who are prescribed hypertonic saline sliding scale
protocol, will need to evaluate each patient and the time it took to achieve serum sodium
>145 with use of sliding scale.
● After patient no longer at risk for cerebral edema, protocol will be discontinued by
provider.
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Table 2 Timeline

01/25/2021: Project start date, education provided to members of neurocritical care time,
questions answered/discussed which patient meet criteria. First and second patient started on
protocol (neuroscience ICU) Second patient NG placed no delay.
01/26-27/2021: First and second patient serum goal achieved, third patient started who was in
ED.
01/28-31/2021: Third patient serum goal achieved (delay with medications) decided not to
start protocol outside of neuroscience ICU. No adverse events from initiation of protocol with
first patient. Data per EMR, recorded (password protected)
02/01/2021: Continue to monitor previous 3 patients placed on protocol, no adverse effects.
02/02/2021: Fourth patient started on protocol in neuroscience ICU.
02/03/2021: Delay with serial lab draws, spoke to laboratory department, education provided
to night staff of neuroscience ICU on protocol, serum sodium goal achieved within 24hour.
02/04-07/2021: No other patient started on protocol: data reviewed. Education continued with
night staff on protocol.
02/11/2021: Fifth patient started on protocol in neuroscience ICU, initiated immediately post
mechanical thrombectomy.
02/12/2021: Serum sodium goal achieved, no adverse effects, monitor data EMR.
02/13/2021: Sixth patient started on protocol in neuroscience ICU.
02/14/2021: Serum sodium goal achieved within 24 hours, no adverse effects, and monitor
date EMR.
02/15-26/2021: No other patients met protocol criteria, looked over data in EMR.
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Figure 1: Serum Sodium Levels

Figure 2: Length of Stay
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Figure 3: Disposition
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Hypertonic Saline Sliding Scale Protocol
•Patient with diagnosed with acute stroke and at risk for cerebral edema will be
admitted to the neuroscience ICU
•Baseline plasma serum sodium level will be obtained, if <140mEq/L Hypertonic
saline sliding scale will be initiated
•Hypertonic saline sliding scale protocol prescribed:
3 grams salt tablets (orally or gastric tube) every 6 hours plus 3% hypertonic saline
will be started 20ml/hour, rate adjusted according to plasma serum sodium results to be
obtain every 6 hours.
•Documentation on all patients who are prescribed hypertonic saline sliding scale
protocol, will need to evaluate each patient and the time it took to achieve serum
sodium >145 with use of sliding scale.
•After patient no longer at risk for cerebral edema, protocol will be discontinued by
provider.

Serum Sodium

Change infusion rate

<130mEq/L

Increase by 20ml/hour (maximum 80ml/hour)

130-135mEq/L

Increase by 10ml/hour (maximum 80ml/hour)

136-145mEq/L

No change in infusion rate

>145mEq/L

Hold infusion, check serum sodium, follow sliding scale

Methods: Translational Framework
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Abstract
Ischemic or hemorrhagic acute strokes are at
times complicated by cerebral edema and its
detrimental effects. I used Hypertonic saline to
obtain therapeutic hypernatremia and prevent
cerebral edema. In a neuroscience intensive
care unit (ICU) setting, patients admitted with
acute stroke and at risk for cerebral edema, are
treated with hypertonic saline. The infusion
rate adjustment varies according to plasma
serum sodium results every 4-6 hours.
Implementation of hypertonic saline sliding
scale protocol, directed serum plasma draw
every 6 hours and utilized use of salt tablets.
Serum sodium goal of 145mEq/L achieved
within 24-hour period; previously 36-52
hours, decreasing length of stay, reducing
costs, and faster disposition.

Methods

Results

Literature Review

Those patients ages 18-99 years admitted to the
current neuroscience ICU setting who suffered an
acute stroke (ischemic or hemorrhagic) within 24-48
hours of admittance and at risk for cerebral edema
were considered for hypertonic saline sliding scale
protocol. Also initial laboratory draw of patient
serum sodium would need to be less than 140mEq/L
to be started on protocol. Rational to start protocol
was to gain proactive approach in preventing any
complication secondary to cerebral edema. Time
frame for prescribing hypertonic saline sliding scale
protocol was January 25 to February 26, 2021.

- 6 patients achieved serum sodium goal
>145mEq/L within 24 hours

Woo et al., (2009) instituted a standardized
hypertonic saline sliding scale, the
retrospective review, of 49 patients, found
the sliding scale protocol easy to use,
simplified treatment, and minimized the
variability among patients.

- Serum sodium levels steadily increased
- Prevented cerebral edema and no
complications
- Decreased length of stay
- Faster disposition
Serum Sodium Levels
148

147

147

143

143

146
144
142

-Education and rationalization of protocol
provided to the neurocritical care team and
neuroscience ICU bedside staff.

139

140

145

145

142

142

145

143
141

139
137

138

145

138

138

Patient 5

Patient 6

136

136
134
132
130
Patient 1

-Variables were analyzed each week

Patient 2

Patient 3

Initial Serum Sodium

Sterns et al., (2013) found Woo et al.
hypertonic saline sliding scale beneficial
when establishing serum sodium goal with
minimal time spent undershooting or
overshooting infusion rates.

Patient 4
12 hour

24 hour

Sterns, R.H., Hix, J.K., & Silver, S.M. (2013). Management of
Hyponatremia in the ICU. Chest, 144, 672-679
Woo, C.H., Rao V.A.,Sheridan, W..,& Flint, A.C. (2009)
Performance4 Characteristics of a Sliding-Scale Infusion
Protocol for the Treatment of Acute Neurologic
Hyponatremia. Neurocritical care, 11(2), 228-234

-Data monitor with EMR

Translational
Framework Model

10-Day Reflective Practice
Log (RPL)/PICOT

Length of Stay
Discharge

17

Patient 5

6

Patient 3

C; Prescribe 1.8% or 3% saline 30-50ml/hr,
rate adjusted at provider’s discretion
O; Serum sodium >145mEq/L

•Patient with diagnosed with acute stroke and at risk for
cerebral edema will be admitted to the neuroscience ICU

8
8

Patient 2

•Baseline plasma serum sodium level obtained, if
<140mEq/L Hypertonic saline sliding scale used

9

5

Patient 1

15
0

I; Use of hypertonic saline sliding scale
protocol

Hypertonic Saline Sliding Scale Protocol

21

5

Patient 4

P: Hospitalized patients ages 18-99 who
suffer acute stroke within 24-48 hours
who are at risk for cerebral edema.

Transfer

Patient 6

5

10

15

20

25

•Protocol prescribed:
3 grams salt tablets (orally or gastric tube) every 6 hours
plus 3% hypertonic saline will be started 20ml/hour, rate
adjusted according to plasma serum sodium results to be
obtain every 6 hours.

Disposition

•Documentation:
• need to evaluate each patient and the time it took to
achieve serum sodium >145 with use of sliding scale.

Quality Improvement Model
1, 17%

•Discontinue protocol, if patient is not at risk for cerebral
edema.

3, 50%
2, 33%

T: Within 24-hour
Home

SNF

Inpatient Rehab

Serum Sodium

Change infusion rate

<130mEq/L

Increase by 20ml/hour (maximum 80ml/hour)

130-135mEq/L

Increase by 10ml/hour (maximum 80ml/hour)

136-145mEq/L

No change in infusion rate

>145mEq/L

Hold infusion, check serum sodium,

follow sliding scale

